Medicare Enrolled
Dr. Rafael Lupercio, M.D.
Critical Care Medicine · Redding, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lupercio from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lupercio?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lupercio
Dr. Rafael Lupercio is a critical care medicine specialist in Redding, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lupercio performed 10,555 Medicare services across 8,489 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lupercio received a total of $10,916 from 27 pharmaceutical and/or device companies across 172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lupercio is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in CA
$10,916 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,555
Medicare services
Top 1% in CA for critical care medicine
8,489
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~556 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,262 | $97 | $300 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
1,172 | $45 | $150 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
1,161 | $42 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,113 | $65 | $200 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
800 | $29 | $175 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
712 | $14 | $50 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
691 | $94 | $275 |
| Albuterol inhalation solution, 1 mg A unit dose of FDA-approved albuterol solution administered via durable medical equipment for inhalation. |
685 | $0 | $2 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
544 | $125 | $450 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
433 | $20 | $100 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using a scope and ultrasound to examine the airways and collect tissue samples from three or more lymph nodes. |
153 | $189 | $2,600 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
143 | $27 | $700 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
109 | $10 | $150 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
87 | $79 | $298 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
81 | $63 | $200 |
| Computer-assisted navigation of lung airways This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation. |
65 | $75 | $4,200 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
58 | $145 | $400 |
| Lung airway biopsy using endoscope A procedure to remove a small tissue sample from the lung airways using a flexible tube with a camera. The sample is examined to check for disease or abnormalities. |
57 | $63 | $950 |
| Levalbuterol inhalation solution, 0.5 mg A 0.5 mg unit dose of FDA-approved levalbuterol inhalation solution administered via durable medical equipment. |
38 | $0 | $2 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
37 | $42 | $125 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
28 | $66 | $1,000 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
27 | $103 | $375 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $128 | $550 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
22 | $15 | $50 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
21 | $76 | $1,300 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
15 | $73 | $250 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
15 | $97 | $320 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,916
Total received (2018-2024)
Avg $1,559/year across 7 years
Top 13% in CA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
172
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,244 (66.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,672 (33.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,289
2023
$1,119
2022
$859
2021
$2,185
2020
$458
2019
$830
2018
$4,176
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$358
Regeneron Healthcare Solutions, Inc.
$313
GlaxoSmithKline, LLC.
$223
Amgen Inc.
$174
Philips North America LLC
$73
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
PFIZER INC.
$41
Electromed, Inc.
$27
Pulmonx Corporation
$21
Merck Sharp & Dohme LLC
$11
Top 3 companies account for 69.4% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,696
GlaxoSmithKline, LLC.
$1,588
US Endoscopy
$1,092
Intuitive Surgical, Inc.
$791
AstraZeneca Pharmaceuticals LP
$530
Regeneron Healthcare Solutions, Inc.
$394
GENZYME CORPORATION
$374
Actelion Pharmaceuticals US, Inc.
$316
Genentech USA, Inc.
$285
Amgen Inc.
$231
United Therapeutics Corporation
$202
Edwards Lifesciences Corporation
$171
Merck Sharp & Dohme LLC
$164
STERIS Corporation
$163
Sunovion Pharmaceuticals Inc.
$151
Abbott Laboratories
$147
Veran Medical Technologies, Inc.
$144
Merck Sharp & Dohme Corporation
$124
Philips North America LLC
$73
Ethicon Inc.
$56
ABIOMED
$47
Grifols USA, LLC
$45
PFIZER INC.
$41
Electromed, Inc.
$27
Olympus America Inc.
$23
Pulmonx Corporation
$21
Bayer Healthcare Pharmaceuticals Inc.
$18
Top 3 companies account for 58.4% of all-time payments
Associated products mentioned in payments ›
(AK6) Vest Therapy · ABRYSVO · AIRSUPRA · ANORO · AREXVY · Adempas · BREZTRI AEROSPHERE · CAPVAXIVE · CHARTIS CATHETER · DUPIXENT · Da Vinci Surgical System · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · Edwards SAPIEN 3 Transcatheter Heart Valve · Esbriet · FASENRA · HeartMate 3 Left Ventricular Assist Device · Impella · LONHALA MAGNAIR · Monarch Platform · NUCALA · OFEV · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR 20 · Prolastin-C Liquid · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Single Use Aspiration Needle NA-U200H · Spin · TAVNEOS · TEZSPIRE · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRELEGY ELLIPTA · TYVASO · TruFreeze · UPTRAVI · UTIBRON · Utibron · WINREVAIR · Xolair · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (66%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
8
Per 100K population
4.4
County median income
$71,931
Nearest hospital
MERCY MEDICAL CENTER REDDING
9.4 mi
9.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lupercio is a clinical cardiology specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement in the top 13% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lupercio experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lupercio performed 2,262 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lupercio receive payments from pharmaceutical companies?
Yes. Dr. Lupercio received a total of $10,916 from 27 companies across 172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lupercio's costs compare to other critical care medicines in Redding?
Dr. Lupercio's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lupercio) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Redding
Browse critical care medicines in Redding ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in CA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in CA
Which CA critical care medicines receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
US Endoscopy Payments to Doctors
See all physicians who received payments from US Endoscopy.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology